BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 250 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $3,843,000 | -11.8% | 26,374 | -74.3% | 1.18% | -34.4% |
| Q1 2022 | $4,359,000 | -60.6% | 102,497 | +27.6% | 1.80% | -59.8% |
| Q4 2021 | $11,073,000 | +28.8% | 80,348 | +29.8% | 4.49% | -7.7% |
| Q3 2021 | $8,598,000 | +56.4% | 61,897 | +9.3% | 4.86% | +98.2% |
| Q2 2021 | $5,497,000 | +60.5% | 56,626 | +13.1% | 2.45% | +31.3% |
| Q1 2021 | $3,424,000 | +142.1% | 50,089 | +203.6% | 1.87% | +127.3% |
| Q4 2020 | $1,414,000 | – | 16,500 | – | 0.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 2,111,111 | $144,294,000 | 54.16% |
| Knoll Capital Management, LLC | 856,844 | $58,565,000 | 38.16% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,123,271 | $145,126,000 | 21.73% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 860,261 | $58,799,000 | 6.01% |
| ARS Investment Partners, LLC | 561,442 | $38,375,000 | 4.46% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $12,057,000 | 3.19% |
| Eventide Asset Management | 2,015,000 | $137,725,000 | 2.04% |
| Avidity Partners Management LP | 1,049,800 | $71,754,000 | 1.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,089 | $3,424,000 | 1.87% |
| Nicholas Investment Partners, LP | 375,654 | $25,676,000 | 1.79% |